Prescription Drug User Fee Act of 1992

Summary

Prescription Drug User Fee Act of 1992 - Amends the Federal Food, Drug, and Cosmetic Act to provide authority for the Secretary of Health and Human Services to assess and collect fees from manufacturers of prescription drugs beginning in FY 1993. Establishes a schedule for prescription drug application and supplement fees, prescription drug establishment fees, and prescription drug product fees. Provides for the annual adjustment of such fees to reflect increases in the Consumer Price Index for urban consumers or increases in Federal pay. Authorizes the Secretary to waive or reduce fees. Prohibits the assessment of fees for a fiscal year after FY 1993 unless appropriations for salaries and expenses of the Food and Drug Administration (FDA) are equal or greater than such appropriations for FY 1992. Credits such fees to the appropriation account for salaries and expenses of the FDA. Authorizes appropriations for FY 1993 through 1997. Provides a mechanism for collecting unpaid fees. Requires the FDA to make annual reports to the Congress on this Act.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 16 September 1992

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 16 September 1992

   Introduced

   Introduced in House

   Source: IntroReferral

3. 16 September 1992

   Introduced

   Introduced in House

   Source: IntroReferral

4. 17 September 1992

   Committee

   Committee Consideration and Mark-up Session Held.

   Source: Committee

5. 17 September 1992

   Reported

   Ordered to be Reported (Amended) by Voice Vote.

   Source: Committee

6. 22 September 1992

   Passed

   On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

   Source: Floor

7. 22 September 1992

   Passed

   Motion to reconsider laid on the table Agreed to without objection.

   Source: Floor

8. 22 September 1992

   Passed

   Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

   Source: Floor

9. 22 September 1992

   Floor

   DEBATE - The House proceeded with forty minutes of debate.

   Source: Floor

10. 22 September 1992

    Floor

    Considered under suspension of the rules.

    Source: Floor

11. 22 September 1992

    Floor

    Mr. Waxman moved to suspend the rules and pass the bill, as amended.

    Source: Floor

12. 22 September 1992

    Calendars

    Placed on the Union Calendar, Calendar No. 512.

    Source: Calendars

13. 22 September 1992

    Reported

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 102-895.

    Source: Committee

14. 22 September 1992

    Reported

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 102-895.

    Source: Committee

15. 24 September 1992

    Introduced

    Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 702. Pursuant to the order of September 22, 1992.

    Source: Calendars

Votes

No vote records are attached yet.

Versions

• Engrossed in House · undated · Official file
• Introduced in House · undated · Official file
• Placed on Calendar Senate · undated · Official file
• Reported in House · undated · Official file

Documents

6 official files

• Reported in House (text)

  Reported in House · EN

  ViewDownloadOpen at official source

• Placed on Calendar Senate (text)

  Placed on Calendar Senate · EN

  ViewDownloadOpen at official source

• Introduced in House (text)

  Introduced in House · EN

  ViewDownloadOpen at official source

• Engrossed in House (text)

  Engrossed in House · EN

  ViewDownloadOpen at official source

• Passed House amended

  summary · EN · 22 September 1992

  Open at official source

• Introduced in House

  summary · EN · 16 September 1992

  Open at official source

Sponsors

• Rep. Dingell, John D. [D-MI-16] · D · Sponsor
• Rep. Waxman, Henry A. [D-CA-24] · D · Sponsor
• Rep. Lent, Norman F. [R-NY-4] · R · Sponsor
• Rep. Boucher, Rick [D-VA-9] · D · Sponsor
• Rep. Bryant, John W. [D-TX-5] · D · Sponsor
• Rep. Harris, Claude [D-AL-7] · D · Sponsor
• Rep. Scheuer, James H. [D-NY-11] · D · Sponsor
• Rep. Studds, Gerry E. [D-MA-12] · D · Sponsor
• Sen. Wyden, Ron [D-OR] · D · Sponsor
• · hsif00 · Standing

Related records

• related to ← To amend the Federal Food, Drug, and Cosmetic Act to authorize human drug application, prescription drug establishment, and prescription drug product fees and for other purposes.